hsCRP/HDL-C ratio

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Cardiometabolic multimorbidity

upin humans1HR 1.38

1 study
  1. hsCRP/HDL-C ratio raises the risk of cardiometabolic multimorbidity in humans (HR 1.38 (95% CI 1.08-1.77) per 0.01 unit increase).

    “Per 0.01 unit increase in CHR correlates with a 38% increase in the risk of CMM (HR = 1.38, 95% CI = 1.08-1.77, p = 0.01) after full adjustment.”

    Humans109 monthsn = 8,187

    The predictive value of hsCRP/HDL-C ratio for cardiometabolic multimorbidity in middle-aged and elderly people: evidence from a large national cohort study

    Frontiers in nutrition10 Jul 2025

More on Cardiometabolic multimorbidity

Latest